Status:
UNKNOWN
Normal Serum Adiponectin Levels in Females
Lead Sponsor:
The Cooper Health System
Conditions:
Diabetes Mellitus
Eligibility:
FEMALE
15-40 years
Phase:
NA
Brief Summary
The purpose of the study is to establish the normal levels of the hormone adiponectin in women. Adiponectin is a newly discovered hormone, which is said to be associated with many changes in the human...
Detailed Description
The prevalence of obesity has increased dramatically in recent years . It is commonly associated with type 2 diabetes, coronary artery disease, and hypertension, and the coexistence of these diseases ...
Eligibility Criteria
Inclusion
- Age: 15 - 40 years old.
- BMI: 18.5 - 24.9
- No medical or chronic health problems.
- If pregnant, singleton.
- First blood sample can be obtained before 13 weeks gestation.
- Plans to continue pregnancy till term and deliver at our hospital
Exclusion
- Hypertension.
- Diabetes Mellitus.
- Ischemic heart disease.
- Metabolic disorders e.g. hyperlipidemia, hypercholesterolemia.
- Endocrinological diseases e.g. thyroid or adrenal diseases.
- Chronic Debilitating diseases e.g. SLE, or Cancer.
- BMI less than18.5 or greater than 25.
- Anorexia or Bulimia.
- Polycystic ovarian disease.
- In pregnant group:
- Multiple gestations.
- Hyperemesis or dehydration.
- History of Gestational Diabetes, Preeclampsia, or other complications with previous pregnancies
- If abnormal weight gain during pregnancy, will continue in the study but would not be included in establishing normal levels.
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00454623
Start Date
March 1 2006
End Date
June 1 2007
Last Update
April 2 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cooper University Hospital
Camden, New Jersey, United States, 08103